Allergic conditions: key references and evidence

References

Key policy documents

Scottish Medical and Scientific Advisory Committee (SMASAC). Immunology and Allergy Services in Scotland. Edinburgh: Scottish Executive, 2000.

Scottish Medical and Scientific Advisory Committee (SMASAC). Report on allergy services in Scotland. Edinburgh: Scottish Government, 2009.

Royal College of Physicians. Allergy: the unmet need. A blueprint for better patient care. (1,064Kb) London, 2003. 

Department of Health. Government response to the House of Commons Health Committee report on the provision of allergy services. (191Kb) London, 2005. 

House of Lords Science and Technology Committee. 6th Report of Session 2006-07 - Allergy. London, 2007.

Joint Royal College of Physicians and Royal College of Pathologists Working Party. Allergy services: Still not meeting the unmet need (475Kb). London, 2010.

Key international comparisons

Asher MI, Montefort S, Bjorksten B, Lai CKW, Strachan DP, Weiland SK et al. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis and eczema in childhood: ISAAC Phase One and Three repeat multicountry cross-sectional surveys. Lancet 2006; 368(9537): 733-743.

European Community Respiratory Health Survey. Variations in the prevalence of respiratory symptoms, self-reported asthma attacks, and use of asthma medication in the European Community Respiratory Health Survey (ECRHS). Eur Respir J 1996;9:687-95.

Pearce N, Sunyer J, Cheng S, Chinn S, Bjorksten B, Burr M et al. Comparison of asthma prevalence in the ISAAC and the ECRHS. ISAAC Steering Committee and European Community Respiratory Health Survey. International Study of Asthma and Allergies in Childhood. Eur respir J 2000; 16(3): 420-426.

Other useful publications

Anandan C, Nurmatov U, van Schayck OCP, Sheikh A. Is the prevalence of asthma declining? Systematic review of epidemiological studies. Allergy 2010; 65(2): 152-167. (PubMed link)

Bellanti, J.A. and Settipane, R.A., 2023, March. The complexities of allergic diseases continue to challenge the allergist-immunologist. In Allergy and Asthma Proceedings (Vol. 44, No. 2, p. 87). OceanSide. (PubMed link)

Deckers IAG, McLean S, Linssen S, Mommers M, van Schayck CP, Sheikh A. Investigating International Time Trends in the Incidence and Prevalence of Atopic Eczema 1990–2010: A Systematic Review of Epidemiological Studies. PLoS ONE 2012; 7: e39803. (PubMed link)

Dierick, B.J., van der Molen, T., Flokstra-de Blok, B.M., Muraro, A., Postma, M.J., Kocks, J.W. and van Boven, J.F., 2020. Burden and socioeconomics of asthma, allergic rhinitis, atopic dermatitis and food allergy. Expert review of pharmacoeconomics & outcomes research20(5), pp.437-453. (PubMed link)

The European Academy of Allergy and Clinical Immunology (EAACI), 2015. Advocacy Manifesto – Tackling the Allergy Crisis in Europe – Concerted Policy Action Needed. Available at: EAACI_Advocacy_Manifesto.pdf

The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis and atopic eczema. Lancet 1998; 351:1225-32. (PubMed link)

Odhiambo JA, Williams HC, Clayton TO, Robertson CF, Asher MI, ISAAC Phase Three Study Group. Global variations in prevalence of eczema symptoms in children from ISAAC Phase Three. J Allergy Clin Immunol 2009; 124(6): 1251-1258. (PubMed link)

Panesar SS, Javad S, de Silva D, et al. The epidemiology of anaphylaxis in Europe: a systematic review. Allergy 2013; 68: 1353–61. (PubMed link)

Papadopoulos, N.G., 2020. Current grand challenges in allergy. Frontiers in Allergy1, p.547654. (PubMed link)

Spergel, J.M., 2010. From atopic dermatitis to asthma: the atopic march. Annals of allergy, asthma & immunology105(2), pp.99-106. (PubMed link)

Warner JO. Worldwide variations in the prevalence of atopic symptoms: what does it all mean? Thorax 1999; 54 (Supplement 2): S46-S51. (PubMed link)

Effectiveness evidence

ScotPHO's purpose is to describe the pattern of health across the Scottish population. As a supplementary service to users, we include the following links to external sources of quality-assured evidence on effectiveness of interventions which may include relevant material for this topic. These links are provided as an aid to users. They are by no means exhaustive nor should they be necessarily viewed as authoritative.

NHS Health Scotland: Scottish briefings on NICE public health guidance

Centre for Reviews and Dissemination

Cochrane Library: Browse by topic

EPPI-Centre: Evidence library

National Institute for Health and Care Excellence (NICE) Evidence services: Evidence search

National Institute for Health and Care Excellence (NICE) Guidance: Find guidance

Scottish Intercollegiate Guidelines Network (SIGN)

 

Please note: ScotPHO is not responsible for the content or reliability of linked websites and does not necessarily endorse the views expressed within them. Listing should not be taken as endorsement of any kind. ScotPHO can take no responsibility for information contained on websites maintained by other organisations or for actions taken as a result of information contained on websites maintained by other organisations.

To report a broken link on the ScotPHO website, please email details to the ScotPHO teamThis e-mail address is being protected from spambots. You need JavaScript enabled to view it of the web page containing the broken link together with the web address you were unable to access.